AGT and hypertensive disorder: Evidence has also shown that selective CysLT1 receptor antagonists were able to mitigate angiotensin II-mediated vasoconstriction in several animal and human models [51–53], therefore, suggesting a strong involvement of CysLT in the pathogenesis of angiotensin II-induced hypertension [54].